本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

CureVac B.V.

5.37
0.0000
盘后5.370.00000.00%16:10 EDT
成交量:49.16万
成交额:263.75万
市值:12.09亿
市盈率:5.34
高:5.39
开:5.35
低:5.32
收:5.37
52周最高:5.72
52周最低:2.37
股本:2.25亿
流通股本:1.26亿
量比:0.89
换手率:0.39%
股息:- -
股息率:- -
每股收益(TTM):1.01
每股收益(LYR):0.7483
净资产收益率:40.22%
总资产收益率:23.77%
市净率:1.77
市盈率(LYR):7.18

数据加载中...

2022/05/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/05

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/05/05

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/05/05

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/27

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/25

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/25

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/25

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/08/27

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/24

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/08/24

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/08/24

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/14

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/08/11

SEC问询函

CORRESP [Cover] - Correspondence